Molecular features assisting in diagnosis, surgery, and treatment decision making in low-grade gliomas.
Neurosurg Focus
; 38(3): E2, 2015 Mar.
Article
en En
| MEDLINE
| ID: mdl-25727224
Palabras clave
1H HR-MAS = proton high-resolution magic angle spinning; 2HG = D-2-hydroxyglutarate; D-2-hydroxyglutarate spectrometry; EORTC = European Organisation for Research and Treatment of Cancer; G-CIMP = glioma CpG island methylator phenotype; GBM = glioblastoma multiforme; HR = hazard ratio; IDH = isocitrate dehydrogenase; LGG = low-grade glioma; MGMT = O6-methylguanine-DNA-methyltransferase; MRS = MR spectroscopy; OS = overall survival; PCV = procarbazine, lomustine, and vincristine; PFS = progression-free survival; RTOG = Radiation Therapy Oncology Group; astrocytoma; brain tumor; glioma; isocitrate dehydrogenase; magnetic resonance spectrometry; oligodendroglioma
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Neoplasias Encefálicas
/
Procedimientos Neuroquirúrgicos
/
Predisposición Genética a la Enfermedad
/
Toma de Decisiones
/
Glioma
Tipo de estudio:
Diagnostic_studies
/
Prognostic_studies
Límite:
Humans
Idioma:
En
Revista:
Neurosurg Focus
Asunto de la revista:
NEUROCIRURGIA
Año:
2015
Tipo del documento:
Article